Patents by Inventor Christopher Lamond Murriel

Christopher Lamond Murriel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION THERAPY FOR TREATMENT OF DISEASE
    Publication number: 20210403553
    Abstract: The present invention provides methods comprising combination therapy for modulating immune responses, for inhibiting tumor growth, and/or for treating cancer. In particular, the present invention provides Notch pathway inhibitors in combination with immunotherapeutic agents for the treatment of cancer and other diseases.
    Type: Application
    Filed: May 26, 2021
    Publication date: December 30, 2021
    Inventors: Christopher Lamond Murriel, Timothy Charles Hoey, Austin L. Gurney, Julie Michelle Roda, Minu K. Srivastava, Inkyung Park, Jakob Dupont
  • Combination therapy for treatment of disease
    Patent number: 11046760
    Abstract: The present invention provides methods comprising combination therapy for modulating immune responses, for inhibiting tumor growth, and/or for treating cancer. In particular, the present invention provides Notch pathway inhibitors in combination with immunotherapeutic agents for the treatment of cancer and other diseases.
    Type: Grant
    Filed: February 6, 2018
    Date of Patent: June 29, 2021
    Assignee: ONCOMED PHARMACEUTICALS, INC.
    Inventors: Christopher Lamond Murriel, Timothy Charles Hoey, Austin L. Gurney, Julie Michelle Roda, Minu K. Srivastava, Inkyung Park, Jakob Dupont
  • Combination Therapy For Treatment Of Disease
    Publication number: 20180273618
    Abstract: The present invention provides methods comprising combination therapy for modulating immune responses, for inhibiting tumor growth, and/or for treating cancer. In particular, the present invention provides Notch pathway inhibitors in combination with immunotherapeutic agents for the treatment of cancer and other diseases.
    Type: Application
    Filed: February 6, 2018
    Publication date: September 27, 2018
    Inventors: Christopher Lamond MURRIEL, Timothy Charles HOEY, Austin L. GURNEY, Julie Michelle RODA, Minu K. SRIVASTAVA, Inkyung PARK, Jakob DUPONT
  • COMBINATION THERAPY FOR TREATMENT OF DISEASE
    Publication number: 20180244783
    Abstract: The present invention provides methods comprising combination therapy for modulating immune responses, for inhibiting tumor growth, and/or for treating cancer. In particular, the present invention provides Wnt pathway inhibitors in combination with immunotherapeutic agents for the treatment of cancer and other diseases.
    Type: Application
    Filed: August 31, 2016
    Publication date: August 30, 2018
    Inventors: Timothy Charles HOEY, Christopher Lamond MURRIEL, Jennifer Anne CAIN
  • Combination Therapy For Treatment Of Disease
    Publication number: 20160176962
    Abstract: The present invention provides methods comprising combination therapy for modulating immune responses, for inhibiting tumor growth, and/or for treating cancer. In particular, the present invention provides Notch pathway inhibitors in combination with immunotherapeutic agents for the treatment of cancer and other diseases.
    Type: Application
    Filed: October 30, 2015
    Publication date: June 23, 2016
    Inventors: Christopher Lamond Murriel, Timothy Charles Hoey, Austin L. Gurney, Julie Michelle Roda, Minu K. Srivastava, Inkyung Park, Jakob Dupont
  • Combination Therapy for Treatment of Cancer
    Publication number: 20150132301
    Abstract: The present invention provides methods comprising combination therapy for treating cancer. In particular, the present invention provides Wnt pathway inhibitors in combination with MAPK pathway inhibitors for the treatment of cancer and other diseases. In some embodiments, the MAPK pathway signaling activation is due to a mutation in a MAPK pathway component. In some embodiments, the MAPK pathway signaling component is Ras, Raf, MEK, or ERK.
    Type: Application
    Filed: December 7, 2012
    Publication date: May 14, 2015
    Inventors: Timothy C. Hoey, Christopher Lamond Murriel